GAIN: from keynote presentations about expected scientific breakthroughs; the major roadblocks blocking adoption of personalised medicine and care; successful policy measures driving personalised medicine; best practices for implementation and more.

CONTRIBUTE: by sharing your vision in setting the joint agenda and giving your input for an integrated European approach for new policies and funding schemes in support of personalised medicine and personalised care. 


Topics to be addressed

This final edition of the Conference will address topics such as:
e-health, big data,
health economics,
education & training.

The bottlenecks?

Translation of research results, the big data, the uptake in clinical practice and reimbursement are some of the bottlenecks hindering a smooth transition towards personalised medicine.

Who should attend?

Policymakers, researchers, doctors and clinicians, patient groups, payers, regional development agencies, funding agencies, investors and analysts, regulators.

Past editions

Latest tweets

Tweets loading...

Follow Us